However, analysis of mRNA data regarding 13 human cancers showed that increased somatic mutation rates were associated with significantly reduced expression levels of NEIL1/2 and significantly increased expression levels of NEIL3, suggesting that NEIL3 overexpression instead promotes somatic mutation rates in cancer [62]. Here, NEIL1 is linked to cancer.